This investigational compound is a triple receptor agonist that targets GLP-1, GIP, and glucagon receptors to study metabolic regulation in animal models.
*COA for Retatrutide 60mg will be available in mid/late August
“Dual component peptide research listing with each analog supplied for separate analytical characterization of ghrh and secretagogue pathway peptides.”
— revolutionpeptidesusa.com
“This product is supplied exclusively for laboratory research and analytical testing purposes.”
— authenticaminosusa.com
“manufactured under strict quality control standards, bpc 157 is produced to ensure high purity, stability, and consistency, supporting reliable and reproducible.”
— lostcoastaminosusa.com



Reviews
There are no reviews yet.